Brief: Celularity Reports Q1 2022 Financial Results And Provides Corporate Update
16/05/2022 22:21
May 16 (Reuters) - Celularity Inc CELU.O :
* CELULARITY REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.48
* Q1 REVENUE $5.9 MILLION
Source text for Eikon: ID:nGNX2BGwwg
Further company coverage: CELU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform